Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Receivables - Accured (2022 - 2023)

Rani Therapeutics Holdings (RANI) has 2 years of Receivables - Accured data on record, last reported at $200000.0 in Q4 2023.

  • For Q4 2023, Receivables - Accured changed 0.0% year-over-year to $200000.0; the TTM value through Dec 2023 reached $200000.0, changed 0.0%, while the annual FY2023 figure was $200000.0, 0.0% changed from the prior year.
  • Receivables - Accured reached $200000.0 in Q4 2023 per RANI's latest filing, roughly flat from $200000.0 in the prior quarter.
  • Across five years, Receivables - Accured topped out at $200000.0 in Q4 2022 and bottomed at $100000.0 in Q1 2023.